Celladon Corporation is a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/15/12 | $43,000,000 |
GBS Venture Partners H&Q Healthcare/Life Sciences Johnson & Johnson Innovation Lundbeckfond Ventures Novartis Venture Funds Pfizer Venture Investments Venrock | undisclosed | |
| 05/07/12 | undisclosed |
GBS Venture Partners Hambrecht and Quist Capital Management Johnson & Johnson Innovation LSP Life Sciences Partners Lundbeckfond Ventures MPM Capital Novartis Venture Funds Pfizer Venture Investments Venrock | undisclosed |
